Radiation Oncology/Therapy: Page 401

Canadian breast cancer survey reveals patient hardship
By AuntMinnie.com staff writers
A recent study of women in Canada found that many had to travel more than 200 km (124.3 miles) to receive breast cancer treatment, according to the Canadian Breast Cancer Network (CBCN).
March 14, 2005
NAS posts record revenues, but loss widens
By AuntMinnie.com staff writers
Radiation therapy firm North American Scientific reported record fiscal fourth-quarter net sales of $9.8 million, up 172.2% compared with the $3.6 million booked in the fourth quarter of 2003.
March 13, 2005
Varian gets FDA OK for nasopharynx applicator set
By AuntMinnie.com staff writers
Varian Medical Systems has received Food and Drug Administration clearance for its Nasopharynx Applicator Set, which is designed to deliver localized radiation therapy in the upper throat area.
March 13, 2005
Intraoperative PET probe spots nonpalpable lesions
A handheld PET probe should "become a routine part of (cancer) surgery," according to a presenter at the Society of Surgical Oncology (SSO) meeting earlier this month in Atlanta.
March 13, 2005
FDA denies Biofield regulatory request
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration has turned down an appeal from breast technology developer Biofield that would have made it easier for the Atlanta-based company to get its flagship product through the regulatory approval process.
March 8, 2005
Nucletron installs Simulix simulator
By AuntMinnie.com staff writers
Radiotherapy provider Nucletron of Veenendaal, the Netherlands, has installed its Simulix Evolution simulator for radiation therapy at Parkridge Medical Center in Chattanooga, TN.
March 8, 2005
Breast MRI OK immediately following biopsy
By Shalmali Pal
There's no reason to delay breast MR after biopsy as the latter procedure does not hamper the modality's sensitivity to cancer size, according to a study in the Journal of Women's Imaging.
March 8, 2005
PET/CT demonstrates staging strength over PET, CT, and PET plus CT
By Jonathan S. Batchelor
VIENNA - The use of dual-modality PET/CT for tumor, lymph node metastasis, and distant metastasis staging is more accurate than CT, PET, or side-by-side PET and CT, according to research presented at the European Congress of Radiology (ECR) on Monday. In addition, the use of PET/CT for oncological staging had a significant impact on patient therapy management when compared with the other modalities.
March 6, 2005
2005 03 07 11 15 17 706
NeoRx adds to coffers
By AuntMinnie.com staff writers
Radiotherapy pharmaceutical developer NeoRx has signed definitive agreements with new institutional investors for a private placement of $4.1 million.
March 6, 2005
MDCT staging may obviate bone scintigraphy in some patients
By Eric Barnes
VIENNA - Cancer patients undergoing full CT staging may not always need a bone scintigraphy exam, thanks to the diagnostic accuracy of multidetector-row CT scanners. A study presented today at the tumor imaging sessions of the 2005 European Congress of Radiology found 16-slice CT to be statistically equivalent to scintigraphy for detecting skeletal metastases.
March 5, 2005
Barco receives FDA nods
By AuntMinnie.com staff writers
Display provider Barco has received U.S. Food and Drug Administration 510(k) clearance for its Colonscreen CT colonography software.
March 3, 2005
GE, IntraMedical partner
By AuntMinnie.com staff writers
GE Healthcare has inked an exclusive agreement with molecular imaging technology developer IntraMedical Imaging to offer a surgical oncology device for localization of tumors and lymph nodes during cancer surgery.
March 3, 2005
Previous Page
Page 401 of 468
Next Page